BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 1706936)

  • 1. The galactose-binding sites of the cytotoxic lectin ricin can be chemically blocked in high yield with reactive ligands prepared by chemical modification of glycopeptides containing triantennary N-linked oligosaccharides.
    Lambert JM; McIntyre G; Gauthier MN; Zullo D; Rao V; Steeves RM; Goldmacher VS; Blättler WA
    Biochemistry; 1991 Apr; 30(13):3234-47. PubMed ID: 1706936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of three oligosaccharide binding sites in ricin.
    Steeves RM; Denton ME; Barnard FC; Henry A; Lambert JM
    Biochemistry; 1999 Sep; 38(36):11677-85. PubMed ID: 10512623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galactose-induced dimerization of blocked ricin at acidic pH: evidence for a third galactose-binding site in ricin B-chain.
    Venkatesh YP; Lambert JM
    Glycobiology; 1997 Apr; 7(3):329-35. PubMed ID: 9147041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modification of the binding site(s) of lectins by an affinity column carrying an activated galactose-terminated ligand.
    Moroney SE; D'Alarcao LJ; Goldmacher VS; Lambert JM; Blättler WA
    Biochemistry; 1987 Dec; 26(25):8390-8. PubMed ID: 3442663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of a high-affinity photolabeling reagent for the Gal/GalNAc lectin of mammalian liver: demonstration of galactose-combining sites on each subunit of rabbit hepatic lectin.
    Lee RT; Lee YC
    Biochemistry; 1986 Nov; 25(22):6835-41. PubMed ID: 2432926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microscale synthesis of dextran-based multivalent N-linked oligosaccharide probes.
    Yoshitani N; Takasaki S
    Anal Biochem; 2000 Jan; 277(1):127-34. PubMed ID: 10610697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of N-linked bovine fetuin glycopeptides to isolated rabbit hepatocytes: Gal/GalNAc hepatic lectin discrimination between Gal beta(1,4)GlcNAc and Gal beta(1,3)GlcNAc in a triantennary structure.
    Townsend RR; Hardy MR; Wong TC; Lee YC
    Biochemistry; 1986 Sep; 25(19):5716-25. PubMed ID: 2430615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and functional properties of genetically engineered ricin B chain lacking galactose-binding activity.
    Vitetta ES; Yen N
    Biochim Biophys Acta; 1990 Jun; 1049(2):151-7. PubMed ID: 1694694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between in vivo toxicity and preclinical in vitro parameters for the immunotoxin anti-B4-blocked ricin.
    Grossbard ML; Lambert JM; Goldmacher VS; Blättler WA; Nadler LM
    Cancer Res; 1992 Aug; 52(15):4200-7. PubMed ID: 1379121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multivalent binding of ricin to bovine serum albumin-based neoglycoconjugates.
    Blome MC; Schengrund CL
    Toxicon; 2008 Jun; 51(7):1214-24. PubMed ID: 18384830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phage display of ricin B chain and its single binding domains: system for screening galactose-binding mutants.
    Swimmer C; Lehar SM; McCafferty J; Chiswell DJ; Blättler WA; Guild BC
    Proc Natl Acad Sci U S A; 1992 May; 89(9):3756-60. PubMed ID: 1373889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of immobilized recombinant mouse C-type macrophage lectin with glycopeptides and oligosaccharides.
    Yamamoto K; Ishida C; Shinohara Y; Hasegawa Y; Konami Y; Osawa T; Irimura T
    Biochemistry; 1994 Jul; 33(26):8159-66. PubMed ID: 7517698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational analysis of the galactose binding ability of recombinant ricin B chain.
    Wales R; Richardson PT; Roberts LM; Woodland HR; Lord JM
    J Biol Chem; 1991 Oct; 266(29):19172-9. PubMed ID: 1717462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors affecting binding of galacto ligands to Actinomyces viscosus lectin.
    Heeb MJ; Marini AM; Gabriel O
    Infect Immun; 1985 Jan; 47(1):61-7. PubMed ID: 2578122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended binding site of ricin B lectin for oligosaccharide recognition.
    Ganguly D; Mukhopadhyay C
    Biopolymers; 2007 Jul; 86(4):311-20. PubMed ID: 17450571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of N-glycosylation on the lectin activity of recombinant ricin B chain.
    Richardson PT; Hussain K; Woodland HR; Lord JM; Roberts LM
    Carbohydr Res; 1991 Jun; 213():19-25. PubMed ID: 1718601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergy between immunotoxins prepared with native ricin A chains and chemically-modified ricin B chains.
    Vitetta ES
    J Immunol; 1986 Mar; 136(5):1880-7. PubMed ID: 2419417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An immunotoxin prepared with blocked ricin: a natural plant toxin adapted for therapeutic use.
    Lambert JM; Goldmacher VS; Collinson AR; Nadler LM; Blättler WA
    Cancer Res; 1991 Dec; 51(23 Pt 1):6236-42. PubMed ID: 1718599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The sugar-combining area of the galactose-specific toxic lectin of mistletoe extends beyond the terminal sugar residue: comparison with a homologous toxic lectin, ricin.
    Lee RT; Gabius HJ; Lee YC
    Carbohydr Res; 1994 Feb; 254():269-76. PubMed ID: 8180989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The specific cytotoxicity of immunoconjugates containing blocked ricin is dependent on the residual binding capacity of blocked ricin: evidence that the membrane binding and A-chain translocation activities of ricin cannot be separated.
    Goldmacher VS; Lambert JM; Blättler WA
    Biochem Biophys Res Commun; 1992 Mar; 183(2):758-66. PubMed ID: 1550582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.